Aditxt, Inc (ADTX)
0.06
-0.02 (25.00%)
Upcoming Events
Latest Headlines
Form 8-K Aditxt, Inc. For: Jun 02
June 5, 2026 4:31 PM - SEC Filing
Form 8-K Aditxt, Inc. For: May 29
June 1, 2026 8:30 AM - SEC Filing
Aditxt names Jeffrey Busch as interim CEO
June 1, 2026 8:15 AM - StreetInsider
Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders
June 1, 2026 8:15 AM - BizWire
Form 8-K Aditxt, Inc. For: May 27
May 29, 2026 4:21 PM - SEC Filing
Form PRE 14A Aditxt, Inc. For: May 22
May 22, 2026 5:04 PM - SEC Filing
Form 10-Q Aditxt, Inc. For: Mar 31
May 20, 2026 4:31 PM - SEC Filing
Form NT 10-Q Aditxt, Inc. For: Mar 31
May 15, 2026 4:28 PM - SEC Filing
Form 8-K Aditxt, Inc. For: May 14
May 15, 2026 4:27 PM - SEC Filing
Aditxt implements 1-for-27 reverse stock split starting May 18
May 14, 2026 8:15 AM - StreetInsider
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026
May 14, 2026 8:15 AM - BizWire
Form 8-K Aditxt, Inc. For: May 06
May 8, 2026 4:20 PM - SEC Filing
Form 8-K Aditxt, Inc. For: May 01
May 1, 2026 4:36 PM - SEC Filing
Form 4 Aditxt, Inc. For: Apr 21 Filed by: HRT FINANCIAL LP
April 27, 2026 3:13 PM - SEC Filing
Form 424B3 Aditxt, Inc.
April 23, 2026 7:12 PM - SEC Filing
Form 4 Aditxt, Inc. For: Apr 21 Filed by: HRT FINANCIAL LP
April 23, 2026 3:43 PM - SEC Filing
Form 3 Aditxt, Inc. For: Apr 21 Filed by: HRT FINANCIAL LP
April 23, 2026 3:37 PM - SEC Filing
Form EFFECT Aditxt, Inc.
April 22, 2026 6:07 AM - SEC Filing
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients
April 20, 2026 8:15 AM - BizWire
Form 8-K Aditxt, Inc. For: Apr 10
April 14, 2026 8:02 AM - SEC Filing
Aditxt, Inc (ADTX) files for 148.28M share offering by selling stockholders
April 13, 2026 6:12 AM - StreetInsider
Form S-3 Aditxt, Inc.
April 13, 2026 6:04 AM - SEC Filing
Form 8-K/A Aditxt, Inc. For: Mar 10
April 7, 2026 4:03 PM - SEC Filing
Form DEF 14A Aditxt, Inc. For: May 01
April 3, 2026 4:37 PM - SEC Filing
Form 8-K Aditxt, Inc. For: Apr 01
April 2, 2026 9:14 AM - SEC Filing
Form 10-K Aditxt, Inc. For: Dec 31
March 31, 2026 4:35 PM - SEC Filing
Form 8-K Aditxt, Inc. For: Mar 27
March 30, 2026 8:01 AM - SEC Filing
Form 424B5 Aditxt, Inc.
March 27, 2026 5:02 PM - SEC Filing
Form PRE 14A Aditxt, Inc. For: Mar 24
March 24, 2026 5:22 PM - SEC Filing
Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary
March 19, 2026 8:15 AM - StreetInsider
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer
March 19, 2026 8:15 AM - BizWire
Form 8-K Aditxt, Inc. For: Mar 10
March 13, 2026 8:36 AM - SEC Filing
Aditxt acquires Ignite Proteomics for $36 million in cancer testing deal
March 13, 2026 8:15 AM - StreetInsider
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection
March 13, 2026 8:15 AM - BizWire
Full Article List
